Part V: Cost pressures, increasing value while improving health outcomes, and leveraging real-world evidence are top of mind.
Part VI: Leaders in healthcare marketing and communications share their thoughts on what excites them about the year ahead.
For the sixteenth year, MedAdNews has chosen a group of new Pharmaceutical Marketing Ventures to Watch that could change the way pharmaceutical products are marketed and sold.
Clinical trials continue to experience a paucity of diversity, but it will take a multipronged approach to infuse DEI into research.
The importance of diversity in clinical research has gained significant recognition, driven by its potential to reduce healthcare disparities, enhance patient outcomes, enrich medical education, and broaden research methodologies. However, consistent underrepresentation of racial and ethnic minorities in clinical trials poses a barrier to the generalizability of research findings.
In its most basic form, market access means ensuring patients can physically get a product. Sounds simple, right?
The talent and tenacity of immigrants can help drive the life sciences industry into the future, if we have the will and wisdom to encourage it.
Customer engagement is instrumental in providing insights on products or services to pharmaceutical decision makers so they can cater to diverse patient needs. It can also help raise and address current challenges, aiding the move towards patient-centric approaches and improving customer satisfaction.
Findings from November’s Veeva Pulse Field Trends Report showed that access to compliant chat expands the engagement channel mix, more than doubling digital touchpoints with HCPs while maintaining or increasing in-person meetings.
“We like to tease that market access is an overnight sensation 20 years in the making. But in all seriousness, market access has always been ultra-important to those of us working in the space, so it’s rewarding to see greater recognition across the industry.” Andrew Gottfried, CEO of Entrée Health, discusses one of the most important and hottest topics in pharma today: market access.
